COR

NYSE · Health Care

Cencora Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks

$333.56

-6.12 (-1.80%)

As of Nov 7, 9:34 PM ET ·

Financial Highlights (FY 2026)

Revenue

316.81B

Net Income

1.53B

Gross Margin

3.5%

Profit Margin

0.5%

Rev Growth

+10.4%

D/E Ratio

5.08

Revenue & Net Income

Margin Trends

	FY 2026	FY 2025	FY 2024	FY 2023
Gross Margin	3.5%	3.5%	43.8%	43.8%
Operating Margin	0.8%	0.7%	8.0%	6.8%
Profit Margin	0.5%	0.5%	5.6%	6.7%

Income Statement

	FY 2026	FY 2025	FY 2024	FY 2023
Revenue	316.81B	286.88B	64.56B	50.79B
Gross Profit	11.12B	10.07B	28.29B	22.26B
Operating Income	2.60B	2.12B	5.17B	3.44B
Net Income	1.53B	1.25B	3.64B	3.39B
Gross Margin	3.5%	3.5%	43.8%	43.8%
Operating Margin	0.8%	0.7%	8.0%	6.8%
Profit Margin	0.5%	0.5%	5.6%	6.7%
Rev Growth	+10.4%	+10.4%	+21.6%	+22.9%

Balance Sheet

	FY 2026	FY 2025	FY 2024	FY 2023
Total Debt	26.82B	26.82B	3.76B	4.55B
Total Equity	5.28B	5.28B	26.18B	25.95B
D/E Ratio	5.08	5.08	0.14	0.18

Cash Flow

	FY 2026	FY 2025	FY 2024	FY 2023
EBITDA	3.63B	3.12B	6.65B	4.98B
Free Cash Flow	—	—	4.33B	3.13B